collection
https://read.qxmd.com/read/19896326/multicenter-double-blind-randomized-placebo-controlled-parallel-group-study-of-the-efficacy-safety-and-tolerability-of-thc-cbd-extract-and-thc-extract-in-patients-with-intractable-cancer-related-pain
#21
RANDOMIZED CONTROLLED TRIAL
Jeremy R Johnson, Mary Burnell-Nugent, Dominique Lossignol, Elena Doina Ganae-Motan, Richard Potts, Marie T Fallon
This study compared the efficacy of a tetrahydrocannabinol:cannabidiol (THC:CBD) extract, a nonopioid analgesic endocannabinoid system modulator, and a THC extract, with placebo, in relieving pain in patients with advanced cancer. In total, 177 patients with cancer pain, who experienced inadequate analgesia despite chronic opioid dosing, entered a two-week, multicenter, double-blind, randomized, placebo-controlled, parallel-group trial. Patients were randomized to THC:CBD extract (n = 60), THC extract (n = 58), or placebo (n = 59)...
February 2010: Journal of Pain and Symptom Management
https://read.qxmd.com/read/31565631/phenibut-addiction-in-a-patient-with-substance-use-disorder
#22
Kan Hong Zheng, Afra Khan, Eduardo D Espiridion
Phenibut, a γ-aminobutyric acid (GABA) analog, is a synthetic, nootropic GABAB receptor agonist used to treat anxiety, insomnia, alcohol withdrawal, and other conditions. The drug is licensed and widely used in Russia however, phenibut can be purchased through online vendors in other countries. The current literature on the effects of phenibut intoxication and withdrawal in humans is limited. In this case report, a 23-year-old male with a history of heavy phenibut and alcohol use presented to the emergency department with suicidal thoughts, somatic complaints, and seeking help with detoxification...
July 24, 2019: Curēus
https://read.qxmd.com/read/30364252/drug-interactions-with-new-synthetic-opioids
#23
REVIEW
Clara Pérez-Mañá, Esther Papaseit, Francina Fonseca, Adriana Farré, Marta Torrens, Magi Farré
Fentanyl, fentanyl analogs, and other new synthetic opioids (NSO) have burst onto the illegal drug market as new psychoactive substances (NPS). They are often sold as heroin to unsuspecting users and produce euphoria through their agonist action on μ- opioid receptors. Their high consumption, often combined with other substances, has led to multiple intoxications during recent years. In some countries, such as the United States, the consumption of opioids, whether for medical or recreational purposes, has become epidemic and is considered a public health problem...
2018: Frontiers in Pharmacology
https://read.qxmd.com/read/25655145/novel-psychoactive-substances-of-interest-for-psychiatry
#24
JOURNAL ARTICLE
Fabrizio Schifano, Laura Orsolini, G Duccio Papanti, John M Corkery
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor agonists, a range of prescribed medications, psychoactive plants/herbs, and a large series of performance and image enhancing drugs. Users are typically attracted by these substances due to their intense psychoactive effects and likely lack of detection in routine drug screenings...
February 2015: World Psychiatry: Official Journal of the World Psychiatric Association (WPA)
https://read.qxmd.com/read/30308378/effect-of-ghb-use-and-ghb-induced-comas-on-dorsolateral-prefrontal-cortex-functioning-in-humans
#25
JOURNAL ARTICLE
Filipa Raposo Pereira, Minni T B McMaster, Nikki Polderman, Yvon D A T de Vries, Wim van den Brink, Guido A van Wingen
BACKGROUND: Gamma-hydroxybutyric acid (GHB) is a recreational drug associated with increasing numbers of GHB-dependent patients and emergency attendances often related to GHB-induced comas. Working memory (WM) deficits have been reported in association with GHB use, and animal studies have shown that GHB induces oxidative stress in vulnerable WM-related brain areas such as the dorsolateral prefrontal cortex (DLPFC). However, the effects of chronic GHB use and multiple GHB-induced comas on WM-related brain function in humans remains unknown...
2018: NeuroImage: Clinical
https://read.qxmd.com/read/30426556/prohedonic-properties-of-gamma-hydroxybutyrate-are-associated-with-changes-in-limbic-resting-state-functional-connectivity
#26
RANDOMIZED CONTROLLED TRIAL
Oliver G Bosch, Fabrizio Esposito, Dario Dornbierer, Robin von Rotz, Rainer Kraehenmann, Philipp Staempfli, Boris B Quednow, Erich Seifritz
OBJECTIVE: Gamma-hydroxybutyrate (GHB) is an endogenous GHB-/GABA-B receptor agonist and a narcolepsy treatment. However, GHB is also abused for its prohedonic effects. On a neuronal level, it was shown that GHB increases regional cerebral blood flow in limbic areas such as the right anterior insula (rAI) and the anterior cingulate cortex (ACC). We aimed to further explore the association between the subjective and neuronal signatures of GHB. METHOD: We assessed subjective effects and resting-state functional connectivity (rsFC) of an rAI- and an ACC-seed in 19 healthy male subjects after GHB (35 mg/kg p...
November 2018: Human Psychopharmacology
https://read.qxmd.com/read/30513473/chemsex-behaviours-among-men-who-have-sex-with-men-a-systematic-review-of-the-literature
#27
JOURNAL ARTICLE
Steven Maxwell, Maryam Shahmanesh, Mitzy Gafos
BACKGROUND: 'Chemsex' is the use of drugs before or during planned sexual events to facilitate, enhance, prolong and sustain the experience. Drugs associated with chemsex are methamphetamine, GHB/GBL, mephedrone, cocaine and ketamine. This review syntheses published research on the antecedents, behaviours and consequences associated with chemsex behaviours among men who have sex with men (MSM). METHODS: Papers from high income countries which were published between January 2000 and September 2018 reporting the use of chemsex drugs before or during sex were identified through Medline, Web of Science, CINAHL and Central...
January 2019: International Journal on Drug Policy
https://read.qxmd.com/read/29722031/indirect-acting-strategy-of-opioid-action-instead-of-direct-receptor-activation-dual-acting-enkephalinase-inhibitors-denkis
#28
REVIEW
R B Raffa, J V Pergolizzi, R Taylor, M H Ossipov
WHAT IS KNOWN AND OBJECTIVE: Although pain is one of the most common afflictions, it is often inadequately managed because the available analgesic options are relatively limited due to insufficient efficacy, unacceptable adverse effects or the potential for misuse or abuse. However, recent publications suggest that an alternative approach-indirect enhancement of endogenous pain-relieving pathways-might be desirable. We review this approach, in particular the dual enkephalinase inhibitors (DENKIs)...
August 2018: Journal of Clinical Pharmacy and Therapeutics
https://read.qxmd.com/read/29949228/abuse-liability-and-therapeutic-potential-of-the-mitragyna-speciosa-kratom-alkaloids-mitragynine-and-7-hydroxymitragynine
#29
JOURNAL ARTICLE
Scott E Hemby, Scot McIntosh, Francisco Leon, Stephen J Cutler, Christopher R McCurdy
Kratom, derived from the plant Mitragyna speciosa, is receiving increased attention as an alternative to traditional opiates and as a replacement therapy for opiate dependence. Mitragynine (MG) and 7-hydroxymitragynine (7-HMG) are major psychoactive constituents of kratom. While MG and 7-HMG share behavioral and analgesic properties with morphine, their reinforcing effects have not been examined to date. 7-HMG, but not MG, substituted for morphine self-administration in a dose-dependent manner in the rat self-administration paradigm...
September 2019: Addiction Biology
https://read.qxmd.com/read/28484399/biochemical-benefits-diagnosis-and-clinical-risks-evaluation-of-kratom
#30
REVIEW
Dimy Fluyau, Neelambika Revadigar
BACKGROUND: Kratom ( Mitragyna speciosa ) is a tropical tree with a long history of traditional use in parts of Africa and Southeast Asia. Kratom is also known as Thom, Thang, and Biak. Its leaves and the teas brewed from them have long been used by people in that region to manage pain and opioid withdrawal and to stave off fatigue. Kratom is actually consumed throughout the world for its stimulant effects and as an opioid substitute (in form of tea, chewed, smoked, or ingested in capsules)...
2017: Frontiers in Psychiatry
https://read.qxmd.com/read/3285124/-designer-drugs-a-problem-in-clinical-toxicology
#31
REVIEW
J F Buchanan, C R Brown
'Designer drugs' are substances intended for recreational use which are derivatives of approved drugs so as to circumvent existing legal restrictions. The term as popularised by the lay press lacks precision. Contrary to the popular belief that 'designer drugs' are original creations, the majority of these agents are 'borrowed' from legitimate pharmaceutical research. They merely represent the most recent developments in the evolution of mind-altering chemicals. The most extensively studied class of psychoactive compounds is the phenylethylamines (mescaline analogues)...
1988: Medical Toxicology and Adverse Drug Experience
https://read.qxmd.com/read/15764732/primate-trace-amine-receptor-1-modulation-by-the-dopamine-transporter
#32
JOURNAL ARTICLE
Gregory M Miller, Christopher D Verrico, Amy Jassen, Martha Konar, Hong Yang, Helen Panas, Mary Bahn, Ryan Johnson, Bertha K Madras
Recently identified trace amine receptors are potential direct targets for drugs of abuse, including amphetamine and 3,4-methylenedioxymethamphetamine (MDMA). We cloned full-length rhesus monkey trace amine receptor 1 (rhTA(1)) that was 96% homologous to human TA(1). The trace amines tyramine and beta-phenylethylamine (PEA) and the monoamine transporter substrates (+/-)-amphetamine and (+/-)-MDMA stimulated cAMP accumulation in rhTA(1)-expressing cell lines, as measured by a cAMP response element-luciferase assay...
June 2005: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/27120492/dependence-on-prescription-opioids
#33
REVIEW
Johannes Just, Martin Mücke, Markus Bleckwenn
BACKGROUND: The incidence of initial prescriptions of opioids for chronic non-cancer pain rose by 37% in Germany from 2000 to 2010. Prescribing practice does not always conform with the recommendations of current guidelines. In the USA, 8-12% of patients with chronic non-cancer pain are opioid-dependent. METHODS: This review is based on publications retrieved by a selective PubMed search and on the German S3 guideline on the long-term use of opioids in non-cancer pain...
April 1, 2016: Deutsches Ärzteblatt International
https://read.qxmd.com/read/26482089/next-generation-of-novel-psychoactive-substances-on-the-horizon-a-complex-problem-to-face
#34
REVIEW
Jolanta B Zawilska, Dariusz Andrzejczak
BACKGROUND: The last decade has seen a rapid and continuous growth in the availability and use of novel psychoactive substances (NPS) across the world. Although various products are labeled with warnings "not for human consumption", they are intended to mimic psychoactive effects of illicit drugs of abuse. Once some compounds become regulated, new analogues appear in order to satisfy consumers' demands and at the same time to avoid criminalization. This review presents updated information on the second generation of NPS, introduced as replacements of the already banned substances from this class, focusing on their pharmacological properties and metabolism, routes of administration, and effects in humans...
December 1, 2015: Drug and Alcohol Dependence
https://read.qxmd.com/read/26195274/ethylphenidate-availability-patterns-of-use-and-acute-effects-of-this-novel-psychoactive-substance
#35
REVIEW
James H Ho, George P Bailey, John R H Archer, Paul I Dargan, David M Wood
PURPOSE: Ethylphenidate is a novel psychoactive substance that is an analogue of methylphenidate. This paper describes its availability, patterns of use, and acute effects. METHODS: Searches of the scientific and grey literature (publicly accessible Internet resources) were undertaken, using the keywords "Ethylphenidate", "Ethyl phenidate", "Ethyl phenyl(piperidin-2-yl)acetate", and "Nopaine", to identify information on the prevalence and patterns of use, desired effects, and toxicity of ethylphenidate...
October 2015: European Journal of Clinical Pharmacology
https://read.qxmd.com/read/26690294/are-we-growing-psychotropics-in-our-backyards-a-case-report-and-literature-review-of-coleus-blumei
#36
REVIEW
Nitin Chopra, Lon Hays
There have been very limited reports of the euphoria experienced under the influence of Coleus blumei--part of a large genus with similarities to various mints and herbs, naturally found in abundance and popular in home gardens. There have been reports of similar properties to Salvia divinorum, which contains the psychoactive neocleordane diterpene salvinorin-A. We present a case of a man in his twenties, with no significant known personal or family psychiatric history, presenting to an emergency room with a psychotic episode after the ingestion of C...
2016: Journal of Addiction Medicine
https://read.qxmd.com/read/26923810/nabilone-for-the-management-of-pain
#37
REVIEW
Corey C Tsang, Mirella G Giudice
Nabilone, a synthetic cannabinoid, is approved in many countries including, but not limited to, Canada, the United States, Mexico, and the United Kingdom for the treatment of severe nausea and vomiting associated with chemotherapy. Clinical evidence is emerging for its use in managing pain conditions with different etiologies. We review the efficacy and safety of nabilone for various types of pain as well as its abuse potential, precautions and contraindications, and drug interactions; summarize pertinent clinical practice guidelines; and provide recommendations for dosing, monitoring, and patient education...
March 2016: Pharmacotherapy
https://read.qxmd.com/read/26989420/loperamide-induced-torsades-de-pointes-a-case-report-and-review-of-the-literature
#38
JOURNAL ARTICLE
O Mukarram, Y Hindi, G Catalasan, J Ward
Abuse of over the counter drugs often gets overlooked by health care providers. Loperamide is one such over the counter drug that is often abused by drug addicts. We present here a case of a young male attaining euphoria from taking massive doses of loperamide. He developed Torsades de Pointes and subsequent cardiac arrest. We found similarities in the progression of myocardial electrical conduction abnormalities among loperamide and other previously known arrhythmogenic drugs. We intend to raise concern over the ease of availability of such drugs over the counter and increase the index of suspicion for over the counter drug abuse from our experience...
2016: Case Reports in Medicine
https://read.qxmd.com/read/26595229/experiences-of-kratom-users-a-qualitative-analysis
#39
JOURNAL ARTICLE
Marc T Swogger, Elaine Hart, Fire Erowid, Earth Erowid, Nicole Trabold, Kaila Yee, Kimberly A Parkhurst, Brittany M Priddy, Zach Walsh
Kratom (Mitragyna speciosa) is a psychoactive plant that has been used since at least 1836 in folk medicine in Southeast Asian countries. More recently, kratom has become widely available in the West and is used for both recreational and medicinal purposes. There has, however, been little scientific research into the short- and long-term effects of kratom in humans, and much of the information available is anecdotal. To supplement the increasing scientific understanding of kratom's pharmacology and research into its effects in animals, we report the results of a qualitative analysis of first-hand descriptions of human kratom use that were submitted to, and published by, a psychoactive substance information website (Erowid...
November 2015: Journal of Psychoactive Drugs
https://read.qxmd.com/read/25588018/novel-psychoactive-substances-designer-drugs-overview-and-pharmacology-of-modulators-of-monoamine-signaling
#40
REVIEW
Matthias Liechti
Novel psychoactive substances are newly used designer drugs ("internet drugs", "research chemicals", "legal highs") potentially posing similar health risks to classic illicit substances. Chemically, many novel psychoactive substances can be classified as phenethylamines, amphetamines, synthetic cathinones, piperazines, pipradrols/piperidines, aminoindanes benzofurans, and tryptamines. Pharmacologically, these substances interact with various monoaminergic targets. Typically, stimulants inhibit the transport of dopamine and noradrenaline (pipradrols, pyrovalerone cathinones) or induce the release of these monoamines (amphetamines and methamphetamine-like cathinones), entactogens predominantly enhance serotonin release (phenylpiperazines, aminoindanes, para-substituted amphetamines, and MDMA-like cathinones) similar to MDMA (ecstasy), and hallucinogens (tryptamines, hallucinogenic phenethylamines) are direct agonists at serotonergic 5-HT2A receptors...
2015: Swiss Medical Weekly
label_collection
label_collection
3936
2
3
2016-03-12 18:44:19
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.